{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:51Z","timestamp":1792802031742,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaut.2024.103302","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T04:04:37Z","timestamp":1724040277000},"page":"103302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses"],"prefix":"10.1016","volume":"148","author":[{"given":"Saeedeh","family":"Ghorbanalipoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Heimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendelien","family":"Veldkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Magens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Zanken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin J.","family":"Neuschutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenche","family":"Chakievska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Kunzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Recke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yask","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Boch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Kalies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-6683","authenticated-orcid":false,"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103302_bib1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103302_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103302_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic autoinflammatory diseases","volume":"109","author":"Krainer","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103302_bib4","first-page":"780","article-title":"On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929","volume":"79","author":"Fleming","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jaut.2024.103302_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2024.103302_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4161\/mabs.19931","article-title":"Marketed therapeutic antibodies compendium","volume":"4","author":"Reichert","year":"2012","journal-title":"mAbs"},{"key":"10.1016\/j.jaut.2024.103302_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaut.2024.103302_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.566608","article-title":"Perspective for precision medicine for tuberculosis","volume":"11","author":"Lange","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103302_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103302_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103302_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.875492","article-title":"Unmet medical needs in chronic, non-communicable inflammatory skin diseases","volume":"9","author":"Ujiie","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2024.103302_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103302_bib13","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2024.103302_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamadermatol.2022.5182","article-title":"Association of rituximab with risk of long-term cardiovascular and metabolic outcomes in patients with pemphigus","volume":"159","author":"Kridin","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaut.2024.103302_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2024.103302_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2024.103302_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bib\/bbr013","article-title":"Exploiting drug-disease relationships for computational drug repositioning","volume":"12","author":"Dudley","year":"2011","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.jaut.2024.103302_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2024.103302_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103302_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065831","article-title":"Drug repositioning as a therapeutic strategy against Streptococcus pneumoniae: cell membrane as potential target","volume":"24","author":"Ortiz-Miravalles","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103302_bib21","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3389\/fmicb.2018.02541","article-title":"Antimicrobial and antibiofilm activity of synergistic combinations of a commercially available small compound library with colistin against Pseudomonas aeruginosa","volume":"9","author":"Torres","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jaut.2024.103302_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00432-021-03545-2","article-title":"Personalized oncology and BRAF(K601N) melanoma: model development, drug discovery, and clinical correlation","volume":"147","author":"Keller","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jaut.2024.103302_bib23","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s13311-021-01134-2","article-title":"A high-throughput chemical screen in DJ-1beta mutant flies identifies zaprinast as a potential Parkinson's disease treatment","volume":"18","author":"Sanz","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jaut.2024.103302_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122832","article-title":"A new functional screening platform identifies colistin sulfate as an enhancer of natural killer cell cytotoxicity","volume":"14","author":"Cortes-Kaplan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jaut.2024.103302_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jimd.12698","article-title":"Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome","volume":"47","author":"Politiek","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jaut.2024.103302_bib26","series-title":"Assay Guidance Manual","article-title":"HTS assay validation","author":"Iversen","year":"2004"},{"key":"10.1016\/j.jaut.2024.103302_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100271","article-title":"Identification of keratinocyte cytoprotectants against toxicity by the multikinase inhibitor sorafenib using drug repositioning","volume":"4","author":"Kamata","year":"2024","journal-title":"JID Innov"},{"key":"10.1016\/j.jaut.2024.103302_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fcimb.2019.00083","article-title":"Identification of off-patent compounds that present antifungal activity against the emerging fungal pathogen Candida auris","volume":"9","author":"de Oliveira","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jaut.2024.103302_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/apm.13014","article-title":"The first wide-scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of auranofin and many additional drugs","volume":"128","author":"Foerster","year":"2020","journal-title":"APMIS"},{"key":"10.1016\/j.jaut.2024.103302_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116938","article-title":"Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis","volume":"71","author":"Le","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jaut.2024.103302_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86961.3","article-title":"Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance","volume":"12","author":"Masson","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jaut.2024.103302_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.713312","article-title":"Topical application of the PI3kbeta-selective small molecule inhibitor TGX-221 is an effective treatment option for experimental epidermolysis bullosa acquisita","volume":"8","author":"Zillikens","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2024.103302_bib33","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.jid.2020.04.025","article-title":"Propranolol is an effective topical and systemic treatment option for experimental epidermolysis bullosa acquisita","volume":"140","author":"Stussel","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103302_bib34","article-title":"Multiple modes of action mediate the therapeutic effect of IVIg in experimental epidermolysis bullosa acquisita","author":"Pipi","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103302_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jdermsci.2017.05.016","article-title":"Increased TREM-1 expression in inflamed skin has no functional impact on the pathogenesis of cutaneous disorders","volume":"88","author":"Drager","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jaut.2024.103302_bib36","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103302_bib37","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1002\/cpph.55","article-title":"Drug discovery for pemphigoid diseases","volume":"84","author":"Kasprick","year":"2019","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.jaut.2024.103302_bib38","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103302_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.1976.tb00840.x","article-title":"Topical cycloheximide in psoriasis","volume":"3","author":"Montes","year":"1976","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.jaut.2024.103302_bib40","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.1980.01640340011006","article-title":"Treatment of psoriasis with daunorubicin and cytarabine","volume":"116","author":"Kohn","year":"1980","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103302_bib41","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.4049\/jimmunol.1300310","article-title":"B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita","volume":"191","author":"Iwata","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103302_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.jaut.2024.103302_bib43","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.1701803","article-title":"Myeloid-specific deletion of mcl-1 yields severely neutropenic mice that survive and breed in homozygous form","volume":"201","author":"Csepregi","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103302_bib44","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jid.2016.12.021","article-title":"The leukotriene B4 and its receptor BLT1 act as critical drivers of neutrophil recruitment in murine bullous pemphigoid-like epidermolysis bullosa acquisita","volume":"137","author":"Sezin","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103302_bib45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2016.04.105","article-title":"Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation","volume":"474","author":"Oh","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2024.103302_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mito.2019.07.006","article-title":"Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease","volume":"49","author":"Miyauchi","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jaut.2024.103302_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2478\/v10007-012-0012-3","article-title":"Immunomodulatory effects of anti-estrogenic drugs","volume":"62","author":"Ray","year":"2012","journal-title":"Acta Pharm."},{"key":"10.1016\/j.jaut.2024.103302_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000523","article-title":"Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology","volume":"3","author":"Caprioli","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2024.103302_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.62.4.341","article-title":"Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies","volume":"62","author":"Sthoeger","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103302_bib50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/jid.2014.453","article-title":"Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita","volume":"135","author":"Hirose","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103302_bib51","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2024.103302_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00023-19","article-title":"High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses","volume":"93","author":"Shen","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2024.103302_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics8020050","article-title":"Identification of FDA-approved drugs with activity against stationary phase bartonella henselae","volume":"8","author":"Li","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.jaut.2024.103302_bib54","article-title":"Identification of pyrvinium, an anthelmintic drug, as a novel anti-adipogenic compound based on the gene expression microarray and connectivity map","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jaut.2024.103302_bib55","article-title":"Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103302_bib56","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41420-021-00654-2","article-title":"Pyrvinium pamoate regulates MGMT expression through suppressing the Wnt\/beta-catenin signaling pathway to enhance the glioblastoma sensitivity to temozolomide","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2024.103302_bib57","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood.2020008720","article-title":"Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease","volume":"137","author":"Zhang","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2024.103302_bib58","doi-asserted-by":"crossref","first-page":"58743","DOI":"10.18632\/oncotarget.11318","article-title":"Computational drugs repositioning identifies inhibitors of oncogenic PI3K\/AKT\/P70S6K-dependent pathways among FDA-approved compounds","volume":"7","author":"Carrella","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2024.103302_bib59","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.0308648100","article-title":"Activation of the Wnt signaling pathway in chronic lymphocytic leukemia","volume":"101","author":"Lu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2024.103302_bib60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2141.2007.06667.x","article-title":"Activation of Wnt\/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia","volume":"138","author":"Khan","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jaut.2024.103302_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2008.04.007","article-title":"New insights into the early molecular events underlying B cell activation","volume":"28","author":"Harwood","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103302_bib62","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cpt1976196802","article-title":"Absorption of pyrvinium pamoate","volume":"19","author":"Smith","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2024.103302_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050659","article-title":"Cardiac glycosides as immune system modulators","volume":"11","author":"Skubnik","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaut.2024.103302_bib64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2265.2005.02420.x","article-title":"Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes","volume":"64","author":"Stygar","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jaut.2024.103302_bib65","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3389\/fimmu.2016.00566","article-title":"The selective estrogen receptor modulator raloxifene inhibits neutrophil extracellular trap formation","volume":"7","author":"Flores","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103302_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000454981","article-title":"G protein-coupled estrogen receptor 1 regulates human neutrophil functions","volume":"2","author":"Rodenas","year":"2017","journal-title":"Biomed. Hub"},{"key":"10.1016\/j.jaut.2024.103302_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mce.2012.04.006","article-title":"Expression pattern and signalling pathways in neutrophil like HL-60 cells after treatment with estrogen receptor selective ligands","volume":"361","author":"Blesson","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jaut.2024.103302_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/resp.12664","article-title":"Tamoxifen as a new therapeutic tool for neutrophilic lung inflammation","volume":"21","author":"Perez","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.jaut.2024.103302_bib69","first-page":"4","article-title":"Tamoxifen-induced lupus erythematosus","volume":"4","author":"Mohammed","year":"2012","journal-title":"J. Drug Metabol. Toxicol."},{"key":"10.1016\/j.jaut.2024.103302_bib70","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jaut.2024.103302_bib71","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1200\/JCO.2018.79.0642","article-title":"Cost effectiveness of chimeric antigen receptor T-cell therapy in relapsed or refractory pediatric B-cell acute lymphoblastic leukemia","volume":"36","author":"Lin","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jaut.2024.103302_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jaut.2015.05.004","article-title":"Allelic and copy-number variations of FcgammaRs affect granulocyte function and susceptibility for autoimmune blistering diseases","volume":"61","author":"Recke","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103302_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015718","article-title":"Ex vivo activity of cardiac glycosides in acute leukaemia","volume":"6","author":"Hallbook","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103302_bib74","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00280-021-04339-6","article-title":"Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells","volume":"88","author":"Huot","year":"2021","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:46:59Z","timestamp":1725803219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":74,"alternative-id":["S0896841124001367"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103302","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103302"}}